Replies to post #81 on Neurocrine Biosciences Inc (NBIX)

[surf1944]

8:33AM Neurocrine Biosci announced that the USPTO has issued a Notice of Allowance for its proprietary Vesicular Monoamine Transporter 2 inhibitor (NBIX) 7.21 : The Notice of Allowance indicates that a composition of matter patent on NBI-98854 will have an initial patent term extending to May 2029.